Invention Grant
- Patent Title: Pyrimidine-2,4-diamine derivatives for treatment of cancer
-
Application No.: US15899061Application Date: 2018-02-19
-
Publication No.: US10174029B2Publication Date: 2019-01-08
- Inventor: Martin Scobie , Thomas Helleday , Tobias Koolmeister , Sylvain Jacques
- Applicant: THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
- Applicant Address: SE Stocksund
- Assignee: THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
- Current Assignee: THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING
- Current Assignee Address: SE Stocksund
- Agency: Foley & Lardner LLP
- Priority: SE1251332 20121127
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D453/02 ; C07B59/00 ; C07D487/04 ; A61K31/519 ; C07D417/12 ; C07D413/12 ; C07D403/14 ; C07D409/04 ; C07D403/12 ; C07D401/14 ; A61K31/5377 ; C07D401/12 ; C07D405/14 ; A61K45/06 ; C07D401/04 ; C07D405/12 ; C07D239/48 ; C07D405/04 ; A61K31/506 ; A61K31/505 ; C07D403/04
Abstract:
A compound of formula I, or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1.
Public/Granted literature
- US20180170929A1 PYRIMIDINE-2,4-DIAMINE DERIVATIVES FOR TREATMENT OF CANCER Public/Granted day:2018-06-21
Information query
